Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples.
3-fluorofentanyl
carfentanil
hair analysis
methoxyacetylfentanyl
opioids
Journal
Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
05
05
2020
revised:
27
05
2020
accepted:
29
05
2020
pubmed:
2
6
2020
medline:
2
10
2021
entrez:
2
6
2020
Statut:
ppublish
Résumé
This study was to validate a LC-MS/MS method for the determination of 17 new synthetic opioids (NSOs) in hair including 3-fluorofentanyl, 3-methylfentanyl, acetylfentanyl, acetylnorfentanyl, alfentanyl, butyrylfentanyl, butyrylnorfentanyl, carfentanil, fentanyl, furanylfentanyl, furanylnorfentanyl, methoxyacetylfentanyl, norcarfentanil, norfentanyl, ocfentanil, sufentanil, and U-47700, and to apply it to 137 authentic samples. Twenty milligrams of hair was decontaminated in dichloromethane and underwent liquid extraction. 10 μL of the reconstituted residue were injected onto the system. The separation was performed in 12 minutes in a gradient mode at a flow rate of 300 μL/min using a Hypersyl Gold PFP column (100 × 2.1 mm i.d., 1.9 μm) maintained at 30°C. Compounds were detected in positive ionization and MRM modes using a TSQ Endura mass spectrometer (ThermoFisher). The method was validated according to EMA guidelines. The LLOQ was in the range 1-50 pg/mg, and the calibration ranged from the LLOQ-1000 pg/mg. Intra- and inter-day accuracy (bias) and precision were < 15%. Extraction recoveries of parent drugs and metabolites were 74-120% and 7-62%, respectively. The matrix effect was in the range 59-126% (CVs ≤ 12.9%). Fentanyl was found in six cases at concentrations of < 1-1650 pg/mg (n = 14 segments). Five fentanyl analogs were quantified in two cases: 3-fluorofentanyl (25-150 pg/mg, n = 5), furanylfentanyl (15-500 pg/mg, n = 5), methoxyacetylfentanyl (500-600 pg/mg, n = 2), acetylfentanyl (1 pg/mg, n = 2), carfentanyl (2.5-3 pg/mg, n = 2). This fully validated method allowed us to test for the first time 3-fluorofentanyl and norcarfentanil in hair among 15 other NSOs, and brings new data regarding 3-fluorofentanyl and methoxyacetylfentanyl hair concentrations.
Substances chimiques
Analgesics, Opioid
0
Benzamides
0
U-47700
0
Fentanyl
UF599785JZ
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1298-1308Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
Products - Data Briefs - Number 329 - November 2018. https://www.cdc.gov/nchs/products/databriefs/db329.htm. Accessed 2 May 2020.
Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;67(5152):1419-1427. https://doi.org/10.15585/mmwr.mm675152e1
Overdose Death Rates, https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed 2 May 2020.
European Drug Report 2019: Trends and Developments. http://www.emcdda.europa.eu/publications/edr/trends-developments/2019. Accessed 2 May 2020.
Counterfeit Prescription Pills Containing Fentanyls: A Global Threat, https://www.hsdl.org/?abstract&did=. Accessed 2 May 2020.
Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2018;134(Pt A):121-132.
Evans-Brown M, Gallegos A, Christie R. Fentanils and synthetic cannabinoids: Driving Greater Complexity into the Drug Situation; an Update from the EU Early Warning-System. http://www.emcdda.europa.eu/publications/rapid-communications/fentanils-and-synthetic-cannabinoids-ews-update_en.
Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users' perceptions of fentanyl-adulterated and -substituted ‘heroin’. Int J Drug Policy. 2017;46:146-155.
Roda G, Faggiani F, Bolchi C, Pallavicini M, Dei CM. Ten years of fentanyl-like drugs: a technical-analytical review. Anal Sci. 2019;35(5):479-491.
Marchei E, Pacifici R, Mannocchi G, Marinelli E, Busardò FP, Pichini S. New synthetic opioids in biological and non-biological matrices: a review of current analytical methods. TrAC Trends Anal Chem. 2018;102:1-15.
Sofalvi S, Schueler HE, Lavins ES, et al. An LC-MS-MS method for the analysis of carfentanil, 3-methylfentanyl, 2-furanyl fentanyl, acetyl fentanyl, fentanyl and norfentanyl in postmortem and impaired-driving cases. J Anal Toxicol. 2017;41(6):473-483.
Fogarty MF, Papsun DM, Logan BK. Analysis of fentanyl and 18 novel fentanyl analogs and metabolites by LC-MS-MS, and report of fatalities associated with methoxyacetylfentanyl and cyclopropylfentanyl. J Anal Toxicol. 2018;42(9):592-604.
Larabi IA, Martin M, Fabresse N, et al. Hair testing for 3-fluorofentanyl, furanylfentanyl, methoxyacetylfentanyl, carfentanil, acetylfentanyl and fentanyl by LC-MS/MS after unintentional overdose. Forensic Toxicol. 2020;38(1):277-286.
Qin N, Xiang P, Shen B, Zhuo X, Shi Y, Song F. Application of a validated UHPLC-MS/MS method for 28 fentanyl-analogue and novel synthetic opioids in whole blood in authentic forensic cases. J Chromatogr B. 2019;1124:82-99.
Allibe N, Fouilhe Sam-Lai N, Willeman T, et al. Norcarfentanil: carfentanil misuse or remifentanil treatment? Forensic Toxicol. 2019;37(2):488-495. https://doi.org/10.1007/s11419-019-00481-2
Maurer HH, Meyer MR. High-resolution mass spectrometry in toxicology: current status and future perspectives. Arch Toxicol. 2016;90(9):2161-2172.
Pleil JD, Isaacs KK. High-resolution mass spectrometry: basic principles for using exact mass and mass defect for discovery analysis of organic molecules in blood, breath, urine and environmental media. J Breath Res. 2016;10(1):012001. https://doi.org/10.1088/1752-7155/10/1/012001
Fabresse N, Larabi IA, Stratton T, et al. Development of a sensitive untargeted LC-HRMS screening devoted to hair analysis through a shared MS2 spectra database: a step towards early detection of new psychoactive substances. Drug Test Anal. 2018;11:697-708.
Boumba VA, Di Rago M, Peka M, Drummer OH, Gerostamoulos D. The analysis of 132 novel psychoactive substances in human hair using a single step extraction by tandem LC/MS. Forensic Sci Int. 2017;279:192-202.
Salomone A, Palamar JJ, Bigiarini R, Gerace E, Di Corcia D, Vincenti M. Detection of fentanyl analogs and synthetic opioids in real hair samples. J Anal Toxicol. 2019;43(4):259-265.
Busardò FP, Carlier J, Giorgetti R, et al. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair. Front Chem. 2019;7:184. https://doi.org/10.3389/fchem.2019.00184
Ramírez Fernández MDM, Wille SMR, Jankowski D, Hill V, Samyn N. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users. Forensic Sci Int. 2020;307:110137. https://doi.org/10.1016/j.forsciint.2019.110137
Larabi IA, Fabresse N, Etting I, et al. Prevalence of new psychoactive substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs. Drug Alcohol Depend. 2019;204:107508. https://doi.org/10.1016/j.drugalcdep.2019.06.011
Larabi IA, Riffi M, Fabresse N, Etting I, Alvarez JC. Validation of an UPLC-MS/MS method for the determination of sixteen synthetic cannabinoids in human hair. Application to document chronic use of JWH-122 following a non-fatal overdose. Toxicol Anal Clin. 2019;31:283-292.
Who Expert Committee on Drug Dependence. Critical Review Report: Orthofluorofentanyl. https://www.who.int/medicines/access/controlled-substances/Orthofluorofentanyl.pdf?ua=1. Accessed 2 May 2020.
Helland A, Brede WR, Michelsen LS, et al. Two hospitalizations and one death after exposure to ortho-fluorofentanyl. J Anal Toxicol. 2017;41(8):708-709.
European monitoring centre for drugs and drug addiction. “Methoxyacetylfentanyl”. http://www.emcdda.europa.eu/system/files/publications/7925/20181015_TDAS18002ENN_PDF.pdf, Accessed 2 May 2020.
Palamar JJ, Salomone A, Bigiarini R, Vincenti M, Acosta P, Tofighi B. Testing hair for fentanyl exposure: a method to inform harm reduction behavior among individuals who use heroin. Am J Drug Alcohol Abuse. 2019;45(1):90-96.
Gaulier JM, Richeval C, Phanithavong M, Brault S, Allorge D, Dumestre-Toulet V. A case report of carfentanil-related fatality in France. Toxicol Anal Clin. 2019;31:323-331.
Kintz P. Hair analysis in forensic toxicology. Wiley Interdiscip Rev Forensic Sci. 2018;e1196. https://doi.org/10.1002/wfs2.1196
Goggin MM, Nguyen A, Janis GC. Identification of unique metabolites of the designer opioid furanyl fentanyl. J Anal Toxicol. 2017;41(5):367-375.
Mardal M, Johansen SS, Davidsen AB, et al. Postmortem analysis of three methoxyacetylfentanyl-related deaths in Denmark and in vitro metabolite profiling in pooled human hepatocytes. Forensic Sci Int. 2018;290:310-317.
Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A. In vitro and in vivo metabolite identification studies for the new synthetic opioids Acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J. 2017;19(4):1102-1122.